Boston Scientific CorporationBSXNYSE
Loading
Gross Profit Over TimeExpanding
Percentile Rank100
3Y CAGR+21.5%
5Y CAGR+20.0%
Year-over-Year Change
Revenue minus cost of goods sold
3Y CAGR
+21.5%/yr
vs +4.5%/yr prior
5Y CAGR
+20.0%/yr
Consistent
Acceleration
+17.1pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.5x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $13.85B | +34.9% |
| 2024 | $10.27B | +16.3% |
| 2023 | $8.83B | +14.5% |
| 2022 | $7.71B | +3.4% |
| 2021 | $7.46B | +33.8% |
| 2020 | $5.58B | -18.9% |
| 2019 | $6.88B | +6.2% |
| 2018 | $6.48B | +10.3% |
| 2017 | $5.87B | +9.9% |
| 2016 | $5.34B | - |